Breaking News, Collaborations & Alliances

Galapagos Earns GSK Milestones

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Galapagos NV has successfully achieved a pre-clinical candidate drug in its osteoarthritis alliance with GlaxoSmithKline. Galapagos also reached milestones on other compounds in the alliance, earning milestone payments totaling $10.5 million. Under this alliance, Galapagos has earned $35 million from GSK to date.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters